• Mon news: Novartis in $745M radiopharma pact. Novo launches Wegovy in China. COVID-era telehealth prescribing extended. Hims & Hers GLP-1 tracker. Promising Gilead liver disease trial. See more on our front page

The New Reality of (what's left of) Merck Employees

Quote




anonymous said:
That post holds true for many big pharma companies....just look at the Sackler family of Purdue....
Click to expand...
At least I never worked at that place. A few from Merck went there. A general statement was they were scumbags anyway. Screwed up family type. Everyone knew what that company was doing. It's like working for Pablo escobar. Such dirty people.
 




anonymous said:
At least I never worked at that place. A few from Merck went there. A general statement was they were scumbags anyway. Screwed up family type. Everyone knew what that company was doing. It's like working for Pablo escobar. Such dirty people.
Click to expand...
We are not the worse. We are not the worse!!!!! That's great news. :)
 








anonymous said:
The absolute farthest thing from BS, actually. But thanks for your input, Kenny Boy.
Click to expand...

Question. I see online rep job I might post for, what does "entry level" chronic care mean? I do have the 4 year degree but no pharmasutcal background. Eye am a floor manager at a Target stor, any innput would be helpful s thank you

How bout the pay. Is it good?
 




















































anonymous said:
Reading the posts about Merck's retirement musings led me to write this. It's time to acknowledge the reality…and Ken Frazieris not going to like what I have to say.

Over the last 12-13 years, Merck has actively minimized it's long-term costs by directly laying off tens of thousands of employees and also "encouraging" the departure of tens of thousands more. At the start of this mess, those in "protected groups" (an actual legal term) technically included employees over 40, but the white males had very little chance of successful age discrimination claims unless they were over 50 when they were pressured out. Hence, Merck was hesitant to target for removal those employees over fifty, in general, as those law suits would have made getting rid of those employees very expensive. Thus, we now have a much older sales force (average age is 51), with a smattering of contract reps and some very young reps that make very little and have virtually no impact on long-term costs (no pension for you!). So, those that were older back then are now retiring employees who are reaching that coveted goal, but it is indeed a shrinking group.

As a former senior manager, I can assure you that this is all true and accurate. Merck's demise began with the fall of Vioxx and was accelerated with the greatest series of R&D failures in pharmaceutical history. In short, Merck is where it is by its own accord. It's sad that more than half of the company's employees have been separated since then, with only a fraction having been replaced at a much smaller cost to the company, all because this company was so horribly managed.

As others have indicated, it is truly tragic that Merck's "leadership" has profited mightily since this all began.The billions of dollars (literally) paid to those executives who conceived and implemented the plan to sever the financial ---and often mental---health of our own fellow employees could have been used to soften the blow to those former employees and their families considerably. Instead, Merck's "leaders" have quietly enriched themselves while destroying countless lives with reckless abandon. It is truly shameful.

The anonymous nature of this forum affords me the opportunity to share this with you. Most of us with legal exposure to sharing information like this simply take their cash and drift away. I simply can't fail to acknowledge that thousands of very good people were made to look guilty as they were dismissed or, more often, pressured to quit by very underhanded means. It is a disgraceful organization.
Click to expand...
 








anonymous said:
On the contrary, Merck has had little luck in acquiring new compounds. Keytruda was apparently a good purchase, but that's the only good move this company has made in 20 years. All the money in the world is worthless if there's nothing worthwhile to spend it on. God knows we couldn't actually produce anything from R&D.
Click to expand...
The world changed. Pharma changed and shifted from primary care to specialty. The only thing Merck had in its specialty bag was the Schering Plough merger products and crappy R&D that couldn’t compete in the market place. Primary care got laid off and they are trying to be a specialty company acting like big pharma. This will ruin oncology like it ruined hospital and it ruined virology. The leaders are stuck with too many people and a bunch of lawyers trying to carve out a place for products that have 10-20% market share or less. Now look at the big pharma spin offs focusing on biosimilars. The world can’t sustain rebates and coupons when insurance companies can get by covering products that are far cheaper. The world is changing- pharma is shifting. Merck is too. Pretend you can stay a sales rep for 10 more years making what you make. Oncology reps are running running to a few meetings a year pretending to be an elite scientific team- really Merck oncology is a reformed primary care pod. Keytruda makes a ton of money and Merck has to have the wrote offs. There is no need for more than 1 Keytruda rep per territory- that is absurd. No other company hires a new rep for a new indication for the same product- Why? 1-2 calls a day justify your job… this is what you think pharma should be like? And then blame upper management for white male issues, lay offs, recession, PTSD etc etc
 




Top Bottom
Back
Quote